BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19436800)

  • 1. Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization.
    Wang Y; Liu XC; Zhao J; Kong XR; Shi RF; Zhao XB; Song CX; Liu TJ; Lu F
    Tex Heart Inst J; 2009; 36(2):89-97. PubMed ID: 19436800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin- and basic fibroblast growth factor-incorporated degradable stent: comparison with traditional transmyocardial revascularization.
    Zhang GW; Liu XC; Mphil YL; Zhao J; Shi RF; Zhao XB; Liu TJ; Lü F; Yang Q; He GW
    J Cardiovasc Surg (Torino); 2011 Apr; 52(2):261-70. PubMed ID: 21460777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin- and basic fibroblast growth factor-incorporated stent: a new promising method for myocardial revascularization.
    Liu XC; Zhao J; Wang Y; Liu TJ; Lü F; He GW
    J Surg Res; 2010 Dec; 164(2):204-13. PubMed ID: 19691971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction.
    Jamaiyar A; Wan W; Ohanyan V; Enrick M; Janota D; Cumpston D; Song H; Stevanov K; Kolz CL; Hakobyan T; Dong F; Newby BZ; Chilian WM; Yin L
    Basic Res Cardiol; 2017 Jul; 112(4):41. PubMed ID: 28540527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF nanoparticles repair the heart after myocardial infarction.
    Oduk Y; Zhu W; Kannappan R; Zhao M; Borovjagin AV; Oparil S; Zhang JJ
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H278-H284. PubMed ID: 29101176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
    Hughes GC; Biswas SS; Yin B; Coleman RE; DeGrado TR; Landolfo CK; Lowe JE; Annex BH; Landolfo KP
    Ann Thorac Surg; 2004 Mar; 77(3):812-8. PubMed ID: 14992878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new transmyocardial degradable stent combined with growth factor, heparin, and stem cells in acute myocardial infarction.
    Wang Y; Liu XC; Zhang GW; Zhao J; Zhang JM; Shi RF; Huang YZ; Zhao CH; Liu TJ; Song CX; Lü F; Yang Q; He GW
    Cardiovasc Res; 2009 Dec; 84(3):461-9. PubMed ID: 19578069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro stress effect on degradation and drug release behaviors of basic fibroblast growth factor--poly(lactic-co-glycolic-acid) microsphere.
    Xiong Y; Yu Z; Lang Y; Hu J; Li H; Yan Y; Tu C; Yang T; Song Y; Duan H; Pei F
    Drug Des Devel Ther; 2016; 10():431-40. PubMed ID: 26869764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pro-angiogenic degradable Mg-poly(lactic-co-glycolic acid) implant combined with rhbFGF in a rat limb ischemia model.
    Bao H; Lv F; Liu T
    Acta Biomater; 2017 Dec; 64():279-289. PubMed ID: 28951330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
    Perets A; Baruch Y; Weisbuch F; Shoshany G; Neufeld G; Cohen S
    J Biomed Mater Res A; 2003 Jun; 65(4):489-97. PubMed ID: 12761840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering strategies to control vascular endothelial growth factor stability and levels in a collagen matrix for angiogenesis: the role of heparin sodium salt and the PLGA-based microsphere approach.
    d'Angelo I; Oliviero O; Ungaro F; Quaglia F; Netti PA
    Acta Biomater; 2013 Jul; 9(7):7389-98. PubMed ID: 23523534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants.
    Zhong Y; Zhang L; Ding AG; Shenderova A; Zhu G; Pei P; Chen RR; Mallery SR; Mooney DJ; Schwendeman SP
    J Control Release; 2007 Oct; 122(3):331-7. PubMed ID: 17706831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of adipose-derived stem cells and control-released basic fibroblast growth factor facilitates angiogenesis in a murine ischemic hind limb model.
    Horikoshi-Ishihara H; Tobita M; Tajima S; Tanaka R; Oshita T; Tabata Y; Mizuno H
    J Vasc Surg; 2016 Dec; 64(6):1825-1834.e1. PubMed ID: 26597457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
    Bai Y; Bai L; Zhou J; Chen H; Zhang L
    Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.
    Formiga FR; Pelacho B; Garbayo E; Abizanda G; Gavira JJ; Simon-Yarza T; Mazo M; Tamayo E; Jauquicoa C; Ortiz-de-Solorzano C; Prósper F; Blanco-Prieto MJ
    J Control Release; 2010 Oct; 147(1):30-7. PubMed ID: 20643169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of myocardial contractility in a porcine model of chronic ischemia using a combined transmyocardial revascularization and gene therapy approach.
    Horvath KA; Lu CY; Robert E; Pierce GF; Greene R; Sosnowski BA; Doukas J
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1071-7. PubMed ID: 15867782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor.
    Kawasuji M; Nagamine H; Ikeda M; Sakakibara N; Takemura H; Fujii S; Watanabe Y
    Ann Thorac Surg; 2000 Apr; 69(4):1155-61. PubMed ID: 10800811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-term effect of stem cells combined with transmyocardial degradable stent on swine model of acute myocardial infarction.
    Luan Y; Liu XC; Zhang GW; Shi RF; Zhao XB; Zhao CH; Liu TJ; Lü F; Yang Q; He GW
    Coron Artery Dis; 2010 Jun; 21(4):233-43. PubMed ID: 20375694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic site selection is important for the successful development of collateral vessels.
    Nishiyama A; Koyama H; Miyata T; Watanabe T
    J Vasc Surg; 2015 Jul; 62(1):190-9. PubMed ID: 24630870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragalosides promote angiogenesis via vascular endothelial growth factor and basic fibroblast growth factor in a rat model of myocardial infarction.
    Yu JM; Zhang XB; Jiang W; Wang HD; Zhang YN
    Mol Med Rep; 2015 Nov; 12(5):6718-26. PubMed ID: 26352430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.